Akognos Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.15 Cr
- Satisfied Charges ₹ 1.45 M
- Revenue Growth 13.01%
- Profit Growth 207.55%
- Ebitda 36.70%
- Net Worth 75.49%
- Total Assets 19.95%
About Akognos Life Sciences
Akognos Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 December 2015 (Nine years and two months 7 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.15 Cr. The company has closed loans amounting to ₹1.45 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Pareek and Seema Kaul serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2015PTC288792
- Company No.
288792
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Akognos Life Sciences Private Limited offer?
Akognos Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Sexual Wellness Products, Fertility Enhancer, Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Pharmaceutical Medicine, Immunosuppressive Drugs, Fitness Supplements.
Who are the key members and board of directors at Akognos Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Pareek  | Director | 10-Aug-2016 | Current |
| Seema Kaul | Director | 02-Aug-2023 | Current |
Financial Performance of Akognos Life Sciences.
Akognos Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.01% increase. The company also saw a substantial improvement in profitability, with a 207.55% increase in profit. The company's net worth Soared by an impressive increase of 75.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akognos Life Sciences?
In 2023, Akognos Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.15 Cr
₹0.15 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 1.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2017 | Indian Bank | ₹1.15 Cr | Open |
| 26 May 2017 | Others | ₹1.45 M | Satisfied |
How Many Employees Work at Akognos Life Sciences?
Akognos Life Sciences has a workforce of 27 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akognos Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akognos Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
